PI
NKTR icon

PineBridge Investments’s Nektar Therapeutics NKTR Stock Holding History

PineBridge Investments’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19
Closed -$10K – 1183
2019
Q2 		$10K Sell
19
-36
-65% -$18.1K ﹤0.01% 1067
2019
Q1 		$28K Sell
55
-617
-92% -$366K ﹤0.01% 978
2018
Q4 		$331K Sell
672
-21
-3% -$12.7K 0.01% 768
2018
Q3 		$633K Buy
693
+668
+2,672% +$570K 0.01% 693
2018
Q2 		$18K Sell
25
-12
-32% -$13.8K ﹤0.01% 1053
2018
Q1 		$60K Sell
37
-8,602
-100% -$11.1M ﹤0.01% 1017
2017
Q4 		$7.74M Buy
8,639
+2,435
+39% +$1.44M 0.2% 128
2017
Q3 		$2.23M Sell
6,204
-42
-0.7% -$13.1K 0.05% 281
2017
Q2 		$1.83M Buy
6,246
+4,908
+367% +$1.42M 0.05% 300
2017
Q1 		$471K Buy
1,338
+16
+1% +$3.6K 0.01% 655
2016
Q4 		$243K Buy
1,322
+163
+14% +$33.1K 0.01% 798
2016
Q3 		$299K Buy
1,159
+7
+0.6% +$1.8K 0.01% 384
2016
Q2 		$246K Buy
1,152
+45
+4% +$10.1K 0.01% 425
2016
Q1 		$228K Sell
1,107
-87
-7% -$16.7K 0.01% 434
2015
Q4 		$301K Buy
1,194
+78
+7% +$16K 0.01% 399
2015
Q3 		$184K Buy
1,116
+105
+10% +$18.6K 0.01% 545
2015
Q2 		$190K Buy
+1,011
New +$174K 0.01% 515

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PineBridge Investments's NKTR Position: Q3 2019 in Review

PineBridge Investments sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 19 shares — an estimated $10K sold.

PineBridge Investments first reported a position in NKTR in Q2 2015 and held it in 17 quarters. The position peaked at $7.74M in Q4 2017. 287 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • PineBridge Investments reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • PineBridge Investments sold 19 Nektar Therapeutics shares in Q3 2019, an estimated $10K.
  • PineBridge Investments first reported a position in Nektar Therapeutics in Q2 2015 and held it in 17 quarters.
  • PineBridge Investments's Nektar Therapeutics position peaked at $7.74M in Q4 2017.
  • 287 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on PineBridge Investments's 13F filing for Q3 2019, filed 13 Nov 2019.